Broad Institute is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease
Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world
Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries
Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential
Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer
Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity
Learn more about a USPTO finding that patents granted to the Broad Institute, MIT and Harvard concerning CRISPR editing of eukaryotic genomes do not interfere with patent claims filed by UC Berkeley and the University of Vienna.Read more
What makes these structural variants more challenging to study (compared to sequence variants), and what's being done to remove those challenges?